Key takeaways
Emgality (galcanezumab) and Maxalt (rizatriptan) are both used to manage migraines, but they work differently and are used in different ways. Emgality is a monoclonal antibody that prevents migraines and treats cluster headaches by blocking a protein called calcitonin-gene related peptide (CGRP). It is given as a monthly injection under the skin. Common side effects include pain and rash at the injection site. On the other hand, Maxalt is a triptan that treats migraines by tightening blood vessels and reducing inflammation. It is taken as an oral tablet or an orally disintegrating tablet (ODT) when a migraine starts. Maxalt can cause dizziness and sleepiness and is available as a lower-cost generic. Emgality is not available in a generic form. Emgality is used for prevention, while Maxalt is used for immediate relief during a migraine attack.
